# Karyopharm Therapeutics Inc. (NASDAQ: KPTI), Newton, MA – FDA Inspections

Source: https://www.keypedia.com/companies/karyopharm-therapeutics-inc/28ffa225-b02c-40a0-8662-5bed25336a5a

> Inspection records and compliance data for Karyopharm Therapeutics Inc. in Newton, Massachusetts. 3 FDA inspections on record, 1 Form 483, last inspected March 15, 2023. Publicly traded as NASDAQ: KPTI.

---

## Details

- Name: Karyopharm Therapeutics Inc.
- FEI Number: 3012640137
- Address Line 1: 85 Wells Ave Fl 2
- City: Newton
- State: Massachusetts
- Zip Code: 02459
- Country Name: United States
- Address: 85 Wells Ave Fl 2, Newton, Massachusetts 02459, United States
- Country: United States

## Stock

- Stock ticker: KPTI
- Exchange: NASDAQ
- Share price: $0.04
- Market cap: $907,258
- Price as of: November 10, 2026

## Related Documents

- FDA Inspection 1202243 - Karyopharm Therapeutics Inc. - 2023-03-15 — classification: No Action Indicated (NAI), source: FDA, date: March 15, 2023
- [EIR - Karyopharm Therapeutics Inc. - 2020-02-28](https://www.keypedia.com/records/eir/karyopharm-therapeutics-inc/bdc34cbe-6742-4e7c-a665-13bee5ed72b3) — source: FDA, date: February 28, 2020
- FDA Inspection 1122926 - Karyopharm Therapeutics Inc. - 2020-02-28 — classification: No Action Indicated (NAI), source: FDA, date: February 28, 2020
- [FDA Inspection 1009153 - Karyopharm Therapeutics Inc. - 2017-02-08](https://www.keypedia.com/records/fda_inspections/karyopharm-therapeutics-inc/8eb40be4-18ba-41d3-b5de-ba4c4b35c3b5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 8, 2017

## Related Companies

- [Exemplar Pharmaceuticals LLC](https://www.keypedia.com/companies/exemplar-pharmaceuticals-llc/151a6f00-549b-403b-b79f-3d979f6246b5)
- [Blueprint Medicines Corporation](https://www.keypedia.com/companies/blueprint-medicines-corporation/92f765e6-81ff-46de-8cb1-dee7e91213fa)
- [Alexion Pharmaceuticals, Inc.](https://www.keypedia.com/companies/alexion-pharmaceuticals-inc/ff74d8e2-db98-41ca-9f7b-b8e9cb8b4015)
- [Citius Pharmaceuticals, Inc.](https://www.keypedia.com/companies/citius-pharmaceuticals-inc/1aa4934c-96a3-4ecb-a923-8ecd4e362d62)
- [Verastem, Inc.](https://www.keypedia.com/companies/verastem-inc/d477d311-6bcc-4a68-ba12-e2255081e340)
- [Servier Pharmaceuticals, LLC.](https://www.keypedia.com/companies/servier-pharmaceuticals-llc/d72f7c9b-a32a-4c7c-97aa-89001e1341aa)
- [Partner Therapeutics, Inc.](https://www.keypedia.com/companies/partner-therapeutics-inc/02b6f3e3-ef3e-4352-9f94-1e462de5f2b4)
- [Alnylam Pharmaceuticals, Inc.](https://www.keypedia.com/companies/alnylam-pharmaceuticals-inc/918c30c3-22a5-436f-88c1-6af91b2c575a)
- [Aveo Pharmaceuticals Inc.](https://www.keypedia.com/companies/aveo-pharmaceuticals-inc/a2eaa018-1540-42fe-9d11-7e0e3b465daa)
- [Vanton Research Laboratory, LLC](https://www.keypedia.com/companies/vanton-research-laboratory-llc/a8b09eac-f6c5-4e79-88d6-df9f7e8d9240)

## Related Officers

- [company_representative](https://www.keypedia.com/people/gary-abernathy/33febbbd-d66f-4ff1-aee7-9a6cef9df794)
- [recipient](https://www.keypedia.com/people/michael-g-kauffman/450f0644-deb6-4cd4-8fed-6a3eb6a71010)
